Prior transfusion of umbilical cord mesenchymal stem cells can effectively alleviate symptoms of motion sickness in mice through interleukin 10 secretion

doi:10.4252/wjSC.v13.i2.177

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7779)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series.

Item

Count

PDF

306

WORD

205

HTML

3335

Figures (1-7)

613

Sum=4459

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

421

Download

1071

Sum=1492

Publishing Process of This Article

Item

Count

Browse

532

Download

1296

Sum=1828

Feb 26, 2021 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Feb 26, 2021; 13(2): 177-192
Published online Feb 26, 2021. doi: 10.4252/wjSC.v13.i2.177

Full Size Figure Download Figure

Figure 1 Immunophenotypes of umbilical cord-derived mesenchymal stem cells determined by flow cytometry. Images illustrate the expression of positive stem markers CD29, CD44, CD73, CD90, and CD105 and negative stem markers CD31, CD45, and CD271.

Citation: Zhu HS, Li D, Li C, Huang JX, Chen SS, Li LB, Shi Q, Ju XL. Prior transfusion of umbilical cord mesenchymal stem cells can effectively alleviate symptoms of motion sickness in mice through interleukin 10 secretion. World J Stem Cells 2021; 13(2): 177-192
URL: https://www.wjgnet.com/1948-0210/full/v13/i2/177.htm
DOI: https://dx.doi.org/10.4252/wjSC.v13.i2.177